Only 36.4% of U.S. Adults Are Free of Cardiovascular Disease Risk Factors in Recent Years
A recent study shows that only 36.4% of U.S. adults had no cardiovascular disease risk factors from August 2021 to 2023, highlighting ongoing challenges in cardiovascular health and prevention.
Recent data from the National Center for Health Statistics reveals that only 36.4% of U.S. adults had no risk factors for cardiovascular disease (CVD) between August 2021 and August 2023. The study, led by Catharine A. Couch, Ph.D., R.D., evaluated the prevalence of common CVD risk factors such as uncontrolled high blood pressure, elevated blood lipids, poor blood glucose control, and high body mass index. Findings showed that while a little over one-third of adults had no risk factors, approximately 28.7% had two or more risk factors, increasing their likelihood of developing cardiovascular problems.
Men were more likely than women to have two or more CVD risk factors (31.7% versus 25.8%). As age increased, the percentage of adults with no CVD risk factors decreased, whereas the proportion with multiple risk factors grew. Additionally, socioeconomic status played a role, with adults from families earning 350% or more of the federal poverty level more likely to be free of risk factors and less likely to have multiple ones.
The data also indicates an upward trend in the prevalence of multiple risk factors compared to previous years. Monitoring these patterns is crucial for understanding the overall cardiovascular health of the U.S. population and guiding preventive strategies.
This analysis emphasizes the importance of ongoing public health efforts to reduce cardiovascular risk factors and promote healthier lifestyles among Americans.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Understanding How Lymphocytes Collaborate and Compete to Defend Against Unknown Viruses
Discover how lymphocytes work together and compete within germinal centers to develop effective antibody responses against unknown viruses, offering critical insights for vaccine development.
Stem Cell Grafts Show Promise in Restoring Myelin in Progressive Multiple Sclerosis Animal Models
Recent research indicates that neural stem cell grafts can successfully promote remyelination in mice with models of progressive multiple sclerosis, opening new avenues for regenerative treatments in MS patients.
Biannual Long-Acting Injection Shows Promise in Managing Resistant Hypertension
A groundbreaking six-month injection of zilebesiran shows significant promise in controlling resistant high blood pressure, potentially transforming hypertension treatment.
Dietary Fats and Their Impact on Severe Childhood Asthma
New research links specific dietary fats to severe, treatment-resistant asthma in children, emphasizing the role of diet in respiratory inflammation and potential new therapies.